Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Novalix logo — Novalix is a premier drug discovery CRO

Novalix

Novalix is a premier drug discovery CRO

Founded 2002 France France 371 employees Corporate Round Total: $2.00M Biotechnology

General Information

Company Name Novalix
Founded Year 2002
Location France France +1
Employees 371
Industries Biotechnology
Funding Stage Corporate Round
Social

Get notified when Novalix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Novalix

Novalix is a premier drug discovery CRO providing services to biotech firms and pharmaceutical companies. The company, founded in 2002, emphasizes the significance of exceptional scientific talent and exclusive resources, offering a range of platforms to improve the success rate during pre-clinical stages. Their slogan, "Novalix is a premier drug discovery CRO," reflects their commitment to leveraging high-quality science for superior outcomes. Based in France, the company recently secured a Corporate Round investment on 07 August 2024, with Bruker being the investor. For additional information, interested parties can visit www.novalix.com.

Taxonomy: Drug discovery, Biophysical technologies, Outsourcing, SPR technology, X-ray protein crystallography, NMR technologies, Medicinal chemistry, Structural biology, Chemical development, Biologics analysis, Pharmaceutical development, Manufacturing support, Epigenetic targets, Native mass spectrometry, Flow chemistry

Services & Products

Drug discovery
pharmacology
biophysics
chemistry
cosmetics
consulting services
technical services

Target Customers

Biotech firms pharmaceutical companies research and development departments clinical development teams

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round •••••• 1 •••• •••• 07 Aug 2024
Venture Round •••••• 2
Investor Investor
15 Dec 2020

Novalix Alternatives & Competitors

Novalix vs
SpiroChem
SpiroChem Switzerland

Where chemistry excellence accelerates innovation

Undisclosed
95 employees
Biotechnology
Compare Novalix vs SpiroChem
Novalix vs
BioSolveIT
BioSolveIT Germany

expect actives!

33 employees
Novalix vs
Synfini, Inc.
Synfini, Inc. United States

The Agile Drug Discovery Company

Unknown
14 employees
AI, Pharmaceutical
Compare Novalix vs Synfini, Inc.
Also compare with: Novalix vs Kalypsys Kalypsys

FAQ About Novalix

Novalix is a premier drug discovery CRO
Novalix was founded in 2002.
Novalix is headquartered in France.
Novalix operates in the following industries: Biotechnology.
Novalix has approximately 371 employees.
Novalix has completed 2 funding rounds, raising a total of $2.00M. The latest funding stage is Corporate Round.
Novalix offers: Drug discovery, pharmacology, biophysics, chemistry, cosmetics, consulting services, technical services.
Top alternatives and competitors to Novalix include SpiroChem, BioSolveIT, Synfini, Inc., Kalypsys, Synthonics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novalix and SpiroChem are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Novalix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes